|
|
 |
Growing the Life Sciences Industry: Improving Access, Affordability & Appropriate Use of Medicines – Can we have it all?
FOR IMMEDIATE RELEASE
OTTAWA, September 24, 2018 – Affordability of and access to innovative medicines are challenges that Canada shares with many other countries around the world. With healthcare budgets stretched and aging populations, those challenges continue to increase. Addressing these issues requires creative policy and market-based approaches that draw on the best ideas from around the world.
On September 25th, expert panellists will meet in Ottawa to discuss global and Canadian approaches to balancing affordability and access, while building a strong life sciences industry.
WHEN: Tuesday, September 25, 2018 from 11:30am-1:30pm
11:45 am Welcome remarks
12:00 pm Panel discussion begins
12:40 pm Panel discussion concludes
1:30 pm Event concludes
WHERE: Fairmont Chateau Laurier Hotel – 1 Rideau Street, Ottawa
WHO:
- Ilse Treurnicht, Former CEO MaRS Discovery District
- Hans Erik Henriksen, CEO Healthcare Denmark
- Sheryl Groeneweg, Director General, Manufacturing & Life Sciences Branch, Innovation Sciences and Economic Development Canada (ISED)
- Brian Hilberdink, President, Novo Nordisk Canada Inc.
For further information or to request one-on-one interviews:
Kerry Allerton
Tel: 647-631-6947
Email: kerall@um.dk